Stocks and InvestingStocks and Investing
Tue, March 30, 2021
Mon, March 29, 2021
Fri, March 26, 2021
Thu, March 25, 2021
Wed, March 24, 2021
Tue, March 23, 2021

Mani Foroohar Maintained (BBIO) at Buy with Increased Target to $75 on, Mar 23rd, 2021


Published on 2024-10-27 16:01:00 - WOPRAI, Mani Foroohar
  Print publication without navigation


Mani Foroohar of SVB Leerink, Maintained "BridgeBio Pharma, Inc." (BBIO) at Buy with Increased Target from $67 to $75 on, Mar 23rd, 2021.

Mani has made no other calls on BBIO in the last 4 months.



There are 3 other peers that have a rating on BBIO. Out of the 3 peers that are also analyzing BBIO, 0 agree with Mani's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Mani


  • Salim Syed of "Mizuho" Maintained at Strong Buy with Increased Target to $86 on, Thursday, March 4th, 2021
  • Paul Choi of "Goldman Sachs" Initiated at Strong Buy and Held Target at $83 on, Tuesday, February 9th, 2021
  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $87 on, Monday, January 11th, 2021